- Acumen Powered by Robins Kaplan LLP®
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Entertainment and Media Litigation
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Fiduciary Disputes
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
-
November 11, 2024Tommy Du Honored With 2024 Sheila Sonenshine Associate Pro Bono Award
-
November 7, 2024Robins Kaplan Achieves National Tier 1 Rankings in Multiple Practice Areas on 2025 Best Law Firms List
-
November 1, 2024Robins Kaplan Recognized for “Tipping the Scales” by Diversity & Flexibility Alliance
-
November 14, 2024Roots, Branches, and Wings: Risks and Rewards of Generational Wealth
-
November 18, 2024Careers in Litigation
-
December 11, 20242024 Year in Review: eDiscovery and Artificial Intelligence
-
November 8, 2024Trademark tensions on the track: Court upholds First Amendment protections in Haas v. Steiner
-
November 8, 2024Destination Skiing And The DOJ's Mountain Merger Challenge
-
November 6, 2024How Recent Patent Damages Precedent May Increase Reasonable Royalty Awards
-
September 16, 2022Uber Company Systems Compromised by Widespread Cyber Hack
-
September 15, 2022US Averts Rail Workers Strike With Last-Minute Tentative Deal
-
September 14, 2022Hotter-Than-Expected August Inflation Prompts Massive Wall Street Selloff
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Depo-Provera Lawsuit: Link to Brain and Spinal Tumors
You must read the following notice before sending an e-mail message to Robins Kaplan LLP.
Any information that you send us in an e-mail message should not be confidential or otherwise privileged information. Sending us an e-mail message will not make you a client of Robins Kaplan LLP. We do not accept representation until we have had an opportunity to evaluate your matter, including but not limited to an ethical evaluation of whether we are in a conflict position to represent you. Accordingly, the information you provide to us in an e-mail should not be information for which you would have an expectation of confidentiality.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.
Robins Kaplan LLP is Investigating Brain & Spinal Tumors Linked to Birth Control Use
Robins Kaplan LLP is investigating claims of women who received the birth control medication Depo-Provera and later developed tumors, known as meningiomas, around the brain or spine. If you received Depo-Provera and developed a tumor, please call us at 1.800.553.9910 or complete our online contact form for a free evaluation.
What is Depo-Provera?
Depo-Provera is a birth control medication, usually administered as a shot, that is used to prevent pregnancy. Pharmaceutical giant Pfizer manufactures Depo-Provera, while several other companies sell a generic version of the medication.
In March 2024, a study published in the British Medical Journal found that women who consistently received Depo-Provera had a 555% increased risk of developing intracranial meningiomas (brain tumors). While most meningiomas are benign and grow slowly, they often require surgical removal due to the pressure they can put on the brain.
The FDA approved Depo-Provera for contraceptive use back in 1992. The current label in the United States does not warn against the increased risk of developing meningiomas but labels in Europe do.
Contact Robins Kaplan for an Evaluation of Your Potential Case
If you have received the birth control medication Depo-Provera and developed a brain tumor, the attorneys at Robins Kaplan may be able to help. Our experienced lawyers can help assess your case and provide crucial support while advocating for your rights.
To discuss your possible case with our team, please call 1.800.553.9910 or complete our online contact form above.
RELATED PROFESSIONALS
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.